| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PROFEESIONAL FEES | 2,500 | 2,500 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| SHORT TERM GAIN/ LOSS | 2023-01 | PURCHASE | 2023-12 | 77,542 | 75,918 | 1,624 | ||||
| LONG TERM GAIN | 2022-12 | PURCHASE | 2023-12 | 199,360 | 222,802 | -23,442 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| BNY MELLON | 141,296 | 149,585 |
| INTEREST IN GIBSON ONCOLOGY | 118,622 | 118,622 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| OFFICE EXPENSES | 107 | |||
| OTHER MISCELLANEOUS | 96 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| NET LOSS FROM PARTNERSHIPS | -6,378 | -6,378 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT ADVISORY FEES | 434 | 434 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| LICENSE FEES | 316 |